Skip to main content
Geoffrey Sonn, MD, Urology, Palo Alto, CA

Geoffrey A. Sonn MD

Surgical Oncology


Associate Professor of Urology at Stanford School of Medicine

Join to View Full Profile
  • 300 Pasteur DrPalo Alto, CA 94304

  • Phone+1 650-723-4000

Dr. Sonn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Geoffrey Sonn is a urologist in Palo Alto, CA and is an Associate Professor of Urology at the Stanford School of Medicine. He received his medical degree from the David Geffen School of Medicine at UCLA and has been in practice for 12 years. He specializes in surgical oncology and is experienced in prostate cancer, kidney cancer, urologic oncology, and minimally invasive urologic surgery.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 2011
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 2005 - 2007
  • Georgetown University
    Georgetown UniversityAB, American Studies, 2001 - 2005
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • Urology
    American Board of Urology Urology

Publications & Presentations

PubMed

Press Mentions

  • 6 Doctors on Biden’s Cancer Diagnosis, How It May Have Arisen and His Treatment Options
    6 Doctors on Biden’s Cancer Diagnosis, How It May Have Arisen and His Treatment OptionsMay 20th, 2025
  • MAHA to Reveal Plan on Kids’ Chronic Diseases
    MAHA to Reveal Plan on Kids’ Chronic DiseasesMay 19th, 2025
  • Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death: Study
    Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death: StudyMarch 27th, 2025
  • Join now to see all

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: